105 related articles for article (PubMed ID: 28682148)
1. Pharmacokinetics of an intracerebroventricularly administered antibody in rats.
Noguchi Y; Kato M; Ozeki K; Ishigai M
MAbs; 2017 Oct; 9(7):1210-1215. PubMed ID: 28682148
[TBL] [Abstract][Full Text] [Related]
2. Cimetidine elimination from the cerebrospinal fluid of the rat.
Whittico MT; Giacomini KM
Pharm Res; 1988 Oct; 5(10):628-33. PubMed ID: 3244614
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of IgG and IgM anti-ganglioside antibodies in rats and monkeys after intrathecal administration.
Bergman I; Burckart GJ; Pohl CR; Venkataramanan R; Barmada MA; Griffin JA; Cheung NK
J Pharmacol Exp Ther; 1998 Jan; 284(1):111-5. PubMed ID: 9435168
[TBL] [Abstract][Full Text] [Related]
4. Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat.
Proescholdt MG; Hutto B; Brady LS; Herkenham M
Neuroscience; 2000; 95(2):577-92. PubMed ID: 10658638
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic approaches to drug distribution in the cerebrospinal fluid based on ventricular administration in beagle dogs.
Levin VA; Landahl HD
J Pharmacokinet Biopharm; 1985 Aug; 13(4):387-403. PubMed ID: 3936919
[TBL] [Abstract][Full Text] [Related]
6. Antibody pharmacokinetics in rat brain determined using microdialysis.
Chang HY; Morrow K; Bonacquisti E; Zhang W; Shah DK
MAbs; 2018; 10(6):843-853. PubMed ID: 29944439
[TBL] [Abstract][Full Text] [Related]
7. Flow Rate and Apparent Volume of Cerebrospinal Fluid in Rhesus Macaques (
Lester McCully CM; Rodgers LT; Garica RC; Thomas ML; Peer CJ; Figg WD; Barnard DE; Warren KE
Comp Med; 2020 Dec; 70(6):526-531. PubMed ID: 33046181
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of distribution of 3H-inulin between the cerebrospinal fluid compartments.
Vladić A; Klarica M; Bulat M
Brain Res; 2009 Jan; 1248():127-35. PubMed ID: 19007752
[TBL] [Abstract][Full Text] [Related]
9. Enhanced circulating half-life and hematopoietic properties of a human granulocyte colony-stimulating factor/immunoglobulin fusion protein.
Cox GN; Smith DJ; Carlson SJ; Bendele AM; Chlipala EA; Doherty DH
Exp Hematol; 2004 May; 32(5):441-9. PubMed ID: 15145212
[TBL] [Abstract][Full Text] [Related]
10. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricularly administered bleomycin in beagles.
Levin VA; Byrd D; Sikic BI; Etiz BB; Campbell J; Borcich JK; Davis RL
Cancer Res; 1985 Aug; 45(8):3810-5. PubMed ID: 2410102
[TBL] [Abstract][Full Text] [Related]
11. Plasma and cerebrospinal fluid pharmacokinetics of the DNA methyltransferase inhibitor, 5-azacytidine, alone and with inulin, in nonhuman primate models.
Lester McCully C; Rodgers LT; Cruz R; Thomas ML; Peer CJ; Figg WD; Warren KE
Neurooncol Adv; 2020; 2(1):vdaa005. PubMed ID: 32309806
[TBL] [Abstract][Full Text] [Related]
12. The cerebrospinal fluid immunoglobulin transcriptome and proteome in neuromyelitis optica reveals central nervous system-specific B cell populations.
Kowarik MC; Dzieciatkowska M; Wemlinger S; Ritchie AM; Hemmer B; Owens GP; Bennett JL
J Neuroinflammation; 2015 Jan; 12():19. PubMed ID: 25626447
[TBL] [Abstract][Full Text] [Related]
13. Neuromyelitis optica study model based on chronic infusion of autoantibodies in rat cerebrospinal fluid.
Marignier R; Ruiz A; Cavagna S; Nicole A; Watrin C; Touret M; Parrot S; Malleret G; Peyron C; Benetollo C; Auvergnon N; Vukusic S; Giraudon P
J Neuroinflammation; 2016 May; 13(1):111. PubMed ID: 27193196
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
[TBL] [Abstract][Full Text] [Related]
15. PBPK model of methotrexate in cerebrospinal fluid ventricles using a combined microdialysis and MRI acquisition.
Brandhonneur N; Noury F; Bruyère A; Saint-Jalmes H; Le Corre P
Eur J Pharm Biopharm; 2016 Jul; 104():117-30. PubMed ID: 27142258
[TBL] [Abstract][Full Text] [Related]
16. The blood-cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter-mediated process.
Tachikawa M; Kasai Y; Takahashi M; Fujinawa J; Kitaichi K; Terasaki T; Hosoya K
J Neurochem; 2008 Oct; 107(2):432-42. PubMed ID: 18752646
[TBL] [Abstract][Full Text] [Related]
17. What determines the CSF concentrations of albumin and plasma-derived IgG?
Seyfert S; Faulstich A; Marx P
J Neurol Sci; 2004 Apr; 219(1-2):31-3. PubMed ID: 15050434
[TBL] [Abstract][Full Text] [Related]
18. Use of anti-coronavirus antibody testing of cerebrospinal fluid for diagnosis of feline infectious peritonitis involving the central nervous system in cats.
Boettcher IC; Steinberg T; Matiasek K; Greene CE; Hartmann K; Fischer A
J Am Vet Med Assoc; 2007 Jan; 230(2):199-205. PubMed ID: 17223751
[TBL] [Abstract][Full Text] [Related]
19. Study on the concentrations of cerebrospinal fluid immunoglobulin G and albumin in children.
Hung KL; Chang MT; Tsai ML; Chen WC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(5):325-31. PubMed ID: 1296442
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular administration of anti-endothelin-1 IgG selectively upregulates endothelin-A and kappa opioid receptors.
Wang X; Xu H; Rothman RB
Neuroscience; 2004; 129(3):751-6. PubMed ID: 15541896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
